68Ga-PSMA-11 PET Identified Tumor Recurrence in Prostatectomy Bed With Rising PSA of 0.9 ng/mL but Negative on MRI and 18F-Fluciclovine PET Scan. (10th April 2022)

• Record Type: Journal Article
• Authors: Xu, Guofan; Lu, Yang
• Is Part Of: Clinical nuclear medicine. Volume 47:Number 4(2022)
• Page Start: 378
• Page End: 379
• Publication Date: 2022-04-10
• Subjects: 68Ga-PSMA-11 PET -- 18F-fluciclovine PET -- MRI -- prostate cancer -- metastasis; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000003994
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract: A 63-year-old man with prostate cancer was treated with prostatectomy who had postoperative PSA of 0.6 ng/mL. A pelvic MRI, whole body bone scan, CT chest and abdomen exams did not show any residual or metastatic prostate disease. His PSA increased to 0.9 ng/mL in two months. A fluciclovine PET did not show any tracer avid metastatic or recurrent disease. A 0.7 cm non-fluciclovine-avid nodule at the left prostatectomy bed was considered benign. A 68 Ga-PSMA-11 PET one month later showed avid radiotracer uptake within this nodule. The patient received androgen deprivation treatment after PSMA PET/CT and responded well.